228 related articles for article (PubMed ID: 37893081)
1. In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer.
Asberger J; Berner K; Bicker A; Metz M; Jäger M; Weiß D; Kreutz C; Juhasz-Böss I; Mayer S; Ge I; Erbes T
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893081
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.
Berner K; Hirschfeld M; Weiß D; Rücker G; Asberger J; Ritter A; Nöthling C; Jäger M; Juhasz-Böss I; Erbes T
Arch Gynecol Obstet; 2022 Jul; 306(1):151-163. PubMed ID: 34889994
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro.
Erbes T; Hirschfeld M; Waldeck S; Rücker G; Jäger M; Willmann L; Kammerer B; Mayer S; Gitsch G; Stickeler E
Int J Hyperthermia; 2016 Sep; 32(6):630-42. PubMed ID: 27380148
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment.
Andrikopoulou A; Shalit A; Zografos E; Koutsoukos K; Korakiti AM; Liontos M; Dimopoulos MA; Zagouri F
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439268
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib.
Yu Y; Liao H; Xie R; Zhang Y; Zheng R; Chen J; Zhang B
Front Oncol; 2020; 10():590813. PubMed ID: 33330073
[TBL] [Abstract][Full Text] [Related]
6. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.
Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J
J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278
[TBL] [Abstract][Full Text] [Related]
7. Distinct microRNA expression pattern in breast cancer cells following anti-neoplastic treatment: A systematic review and functional analysis of microRNA target genes.
Qatrun Nada D; Masniza ML; Abdullah N; Marlini M; Elias MH; Pathmanathan SG; Hayati AR; Fadlul Azim F; Hamid AA; Nur Fariha MM
Malays J Pathol; 2022 Dec; 44(3):367-385. PubMed ID: 36591707
[TBL] [Abstract][Full Text] [Related]
8. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients.
Khalighfard S; Alizadeh AM; Irani S; Omranipour R
Sci Rep; 2018 Dec; 8(1):17981. PubMed ID: 30568292
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
[TBL] [Abstract][Full Text] [Related]
11. Effect of a high-intensity interval training on serum microRNA levels in women with breast cancer undergoing hormone therapy. A single-blind randomized trial.
Alizadeh S; Isanejad A; Sadighi S; Khalighfard S; Alizadeh AM
Ann Phys Rehabil Med; 2019 Sep; 62(5):329-335. PubMed ID: 31400480
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients.
Said MN; Muawia S; Helal A; Fawzy A; Allam RM; Shafik NF
Exp Mol Pathol; 2021 Dec; 123():104718. PubMed ID: 34752733
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
Chiorino G; Petracci E; Sehovic E; Gregnanin I; Camussi E; Mello-Grand M; Ostano P; Riggi E; Vergini V; Russo A; Berrino E; Ortale A; Garena F; Venesio T; Gallo F; Favettini E; Frigerio A; Matullo G; Segnan N; Giordano L
Sci Rep; 2023 Jul; 13(1):12040. PubMed ID: 37491482
[TBL] [Abstract][Full Text] [Related]
14. Down-Regulation of circulating miR-23a-3p, miR-101-3p, and miR-let-7c in Women with Idiopathic Recurrent Pregnancy Loss.
Tutunfroush M; Ghorbian S; Mohseni J; Danaii S; Rad MG
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250827
[TBL] [Abstract][Full Text] [Related]
15. Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells.
Ogata R; Kishino E; Saitoh W; Koike Y; Kurebayashi J
Breast Cancer; 2021 Jan; 28(1):206-215. PubMed ID: 32860163
[TBL] [Abstract][Full Text] [Related]
16. [MicroRNA differential expression profile in tuberous sclerosis complex cell line TSC2
Cai Y; Guo H; Li HZ; Wang WD; Zhang YS
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):580-584. PubMed ID: 28816269
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib.
Shivapurkar N; Vietsch EE; Carney E; Isaacs C; Wellstein A
Clin Transl Med; 2017 Oct; 6(1):37. PubMed ID: 28980224
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiles associated with the metastatic ability of MDA‑MB‑231 breast cancer cells.
Phannasil P; Akekawatchai C; Jitrapakdee S
Oncol Lett; 2023 Aug; 26(2):339. PubMed ID: 37427352
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells.
Masri S; Liu Z; Phung S; Wang E; Yuan YC; Chen S
Breast Cancer Res Treat; 2010 Nov; 124(1):89-99. PubMed ID: 20054641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
